Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Methylphenidate promotes the interaction between motor cortex facilitation and attention in healthy adults: A combined study using event-related potentials and transcranial magnetic stimulation.

Berger C, Müller-Godeffroy J, Marx I, Reis O, Buchmann J, Dück A.

Brain Behav. 2018 Dec;8(12):e01155. doi: 10.1002/brb3.1155. Epub 2018 Nov 12.

2.

European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W.

Eur Respir J. 2016 Jul;48(1):283-4. doi: 10.1183/13993003.00604-2016. No abstract available.

3.

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers.

Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, Wuyts W.

Eur Respir J. 2016 Feb;47(2):597-606. doi: 10.1183/13993003.01204-2015. Epub 2015 Nov 19.

4.

IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.

Duck A, Pigram L, Errhalt P, Ahmed D, Chaudhuri N.

Adv Ther. 2015 Feb;32(2):87-107. doi: 10.1007/s12325-015-0183-7. Epub 2015 Feb 18. Review.

5.

Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis.

Duck A, Spencer LG, Bailey S, Leonard C, Ormes J, Caress AL.

J Adv Nurs. 2015 May;71(5):1055-65. doi: 10.1111/jan.12587. Epub 2014 Dec 23.

6.

Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.

Hässler F, Dück A, Jung M, Reis O.

J Child Adolesc Psychopharmacol. 2014 Dec;24(10):579-81. doi: 10.1089/cap.2014.0066.

PMID:
25514543
7.

Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA).

Yorke J, Spencer LG, Duck A, Ratcliffe S, Kwong GN, Longshaw MS, Belkin A, Swigris JJ.

BMJ Open Respir Res. 2014 May 13;1(1):e000024. doi: 10.1136/bmjresp-2014-000024. eCollection 2014.

8.

Management of idiopathic pulmonary fibrosis.

Duck A.

Nurs Times. 2014 Apr 16-22;110(16):16-7.

PMID:
24834600
9.

Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.

Chaudhuri N, Duck A, Frank R, Holme J, Leonard C.

Respir Med. 2014 Jan;108(1):224-6. doi: 10.1016/j.rmed.2013.11.005. Epub 2013 Nov 15.

10.

Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit?

Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E.

Eur Respir J. 2012 Jul;40(1):269-70. doi: 10.1183/09031936.00007712. No abstract available.

11.

Effect of recording site on pulse oximetry readings.

Barnett E, Duck A, Barraclough R.

Nurs Times. 2012 Jan 10-16;108(1-2):22-3.

PMID:
22428284
12.

I've been made to feel like a number, not like a person.

Duck A.

Nurs Times. 2011 Apr 19-May 2;107(15-16):23. No abstract available.

PMID:
21661489
13.

Principles to effectively manage people with interstitial lung disease in the community.

Duck A.

Nurs Times. 2009 Dec 15-2010 Jan 11;105(49-50):29-30. Review.

PMID:
20169853
14.

Does oxygen need humidification?

Duck A.

Nurs Times. 2009 Dec 15-2010 Jan 11;105(49-50):28. No abstract available.

PMID:
20169852
15.

Does oxygen need to be prescribed?

Duck A.

Nurs Times. 2009 Mar 17-23;105(10):19. No abstract available.

PMID:
19400338
16.

[Alternative agents used in ADHD].

Hässler F, Dück A, Reis O, Buchmann J.

Z Kinder Jugendpsychiatr Psychother. 2009 Jan;37(1):13-24, quiz 24-5. doi: 10.1024/1422-4917.37.1.13. Review. German.

PMID:
19105161
17.

Nursing patients with interstitial lung disease.

Duck A.

Nurs Times. 2008 Mar 4-10;104(9):46-9.

PMID:
18411998
18.

Interstitial lung diseases 2: management strategies.

Duck A.

Nurs Times. 2007 Oct 30-Nov 5;103(44):26-7.

PMID:
18019387
19.

Interstitial lung diseases. 1: Diagnosis and investigation.

Duck A.

Nurs Times. 2007 Oct 23-29;103(43):28-9.

PMID:
17993116
20.

Focal adhesion contact formation by fibroblasts cultured on surface-modified dental implants: an in vitro study.

Grössner-Schreiber B, Herzog M, Hedderich J, Dück A, Hannig M, Griepentrog M.

Clin Oral Implants Res. 2006 Dec;17(6):736-45.

PMID:
17092235
21.

Cost-effectiveness and efficacy in long-term oxygen therapy.

Duck A.

Nurs Times. 2006 Feb 14-20;102(7):46-50. Review.

PMID:
16512050
22.

Do different implant surfaces exposed in the oral cavity of humans show different biofilm compositions and activities?

Groessner-Schreiber B, Hannig M, Dück A, Griepentrog M, Wenderoth DF.

Eur J Oral Sci. 2004 Dec;112(6):516-22.

PMID:
15560835

Supplemental Content

Support Center